# Intrathecal Nalbuphine Versus Midazolam in Cesarean Section

> **NCT03918187** · PHASE1 · COMPLETED · sponsor: **Zagazig University** · enrollment: 90 (actual)

## Conditions studied

- Cesarean Section Pain

## Interventions

- **DRUG:** Bupivacaine
- **DRUG:** Nalbuphine
- **DRUG:** Midazolam

## Key facts

- **NCT ID:** NCT03918187
- **Lead sponsor:** Zagazig University
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-10
- **Primary completion:** 2019-08-30
- **Final completion:** 2019-12-01
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2019-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03918187

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03918187, "Intrathecal Nalbuphine Versus Midazolam in Cesarean Section". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT03918187. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*